Hospital General Universitario Gregorio Marañon - Servicio de Oncologia Medica

Madrid 28007

0 studies enrolling now · 7 studies all time

What they study most

Biliary Tract Cancer, Cholangiocarcinoma, Gallbladder Cancer, Gastric Cancer, Locally Advanced or Metastatic Urothelial Carcinoma, Non-Small Cell Lung Cancer, Non-Small Cell Lung Cancer (NSCLC), Non-small Cell Lung Cancer, Pancreatic Cancer, Pancreatic Ductal Adenocarcinoma (PDAC), Solid Tumors, Triple Negative Breast Neoplasms

Studies at this site

• Study of Anti-CEACAM5 ADC M9140 in Participants With Advanced Solid Tumors (PROCEADE PanTumor) — Running, not enrolling
• Avelumab Program Rollover Study — Running, not enrolling
• Tuvusertib (M1774) in Combination With Cemiplimab in Participants With Non-Squamous NSCLC (DDRiver NSCLC 322) — Running, not enrolling
• A Study of the Safety and Efficacy of Various Combinations of Avelumab as Therapy in Locally Advanced or Metastatic Urothelial Carcinoma (JAVELIN Bladder Medley) — Running, not enrolling
• M7824 Versus Pembrolizumab as a First-line (1L) Treatment in Participants With Programmed Death-ligand 1 (PD-L1) Expressing Advanced Non-small Cell Lung Cancer (NSCLC) — Completed
• Gemcitabine Plus Cisplatin With or Without Bintrafusp Alfa (M7824) in Participants With 1L BTC — Stopped early
• Bintrafusp Alfa in High Mobility Group AT-Hook 2 (HMGA2) Expressing Triple Negative Breast Cancer — Stopped early